u/wisesheets

Top comment on the post explicitly names China and software stocks as areas with potential value, supported by the author’s mention of optically cheap EM valuations. The market may be overpricing geopolitical and governance risks in China, creating a margin of safety if earnings hold up or reforms continue. Long FXI as a diversified bet on undervalued Chinese equities with a catalyst from improving sentiment or policy support. Escalating US-China tensions, regulatory crackdowns, or a slowdown in Chinese GDP could widen the discount.

The same top comment highlights “software stocks” alongside China, implying they are overlooked for value. The broader tech sell-off may have created entry points in quality software names. Many enterprise software firms have recurring revenue and strong balance sheets, yet trade at compressed multiples due to macroeconomic fears, offering a potential re-rating when sentiment pivots. Long IGV to capture a basket of software companies that could benefit from normalization of growth expectations and AI adoption. Further rate hikes, persistent inflation, or a recession that cuts IT budgets.

The author has recently added Microsoft to their holdings and notes that the company's EPV-to-MIVoG ratio is 40%. The author states that a 40% ratio has "historically yielded great returns" according to the model's framework, implying that the market's growth expectations for Microsoft are reasonable or pessimistic, creating an attractive entry point. Microsoft is presented as a long-term investment opportunity because its current valuation, when analyzed through the "Value of Growth" model, suggests that the level of growth priced in by the market is historically associated with strong future performance. The historical correlation between a 40% ratio and great returns may not hold in the future. A slowdown in Microsoft's key growth drivers (e.g., cloud computing, AI) or a broader market downturn could lead to underperformance, regardless of the initial valuation. The model's inputs (e.g., normalized NOPAT) are subject to interpretation and could be miscalculated.